Vascular endothelium - Gatekeeper of vessel health

被引:365
作者
Cahill, Paul A. [1 ]
Redmond, Eileen M. [2 ]
机构
[1] Dublin City Univ, Vasc Biol & Therapeut Lab, Dublin 9, Ireland
[2] Univ Rochester, Med Ctr, Dept Surg, Box SURG,601 Elmwood Ave, Rochester, NY 14642 USA
关键词
Endothelium; Endothelial dysfunction; Atherosclerosis; Cardiovascular disease; Vessel remodeling; Clinical therapies; Review; FLUID SHEAR-STRESS; LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; PLASMINOGEN-ACTIVATOR INHIBITOR-1; TO-MESENCHYMAL TRANSITION; REGULAR PHYSICAL-EXERCISE; CORONARY-ARTERY-DISEASE; FACTOR-B CHAIN; SMOOTH-MUSCLE;
D O I
10.1016/j.atherosclerosis.2016.03.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vascular endothelium is an interface between the blood stream and the vessel wall. Changes in this single cell layer of the artery wall are believed of primary importance in the pathogenesis of vascular disease/atherosclerosis. The endothelium responds to humoral, neural and especially hemodynamic stimuli and regulates platelet function, inflammatory responses, vascular smooth muscle cell growth and migration, in addition to modulating vascular tone by synthesizing and releasing vasoactive substances. Compromised endothelial function contributes to the pathogenesis of cardiovascular disease; endothelial 'dysfunction' is associated with risk factors, correlates with disease progression, and predicts cardiovascular events. Therapies for atherosclerosis have been developed, therefore, that are directed towards improving endothelial function. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 109
页数:13
相关论文
共 233 条
[81]  
Heo KS, 2014, MOL CELLS, V37, P435, DOI [10.14348/molcells.2014.0078, 10.14348/molcells.2014.0108]
[82]   Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease [J].
Hou, Luqia ;
Kim, Joseph J. ;
Woo, Y. Joseph ;
Huang, Ngan F. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 310 (04) :H455-H465
[83]   Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications [J].
Hsieh, Hsyue-Jen ;
Liu, Ching-Ann ;
Huang, Bin ;
Tseng, Anne H. H. ;
Wang, Danny Ling .
JOURNAL OF BIOMEDICAL SCIENCE, 2014, 21
[84]   Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments [J].
Huxley, VH ;
Williams, DA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (04) :H1177-H1185
[85]   ENDOTHELIUM-DERIVED NITRIC-OXIDE - ACTIONS AND PROPERTIES [J].
IGNARRO, LJ .
FASEB JOURNAL, 1989, 3 (01) :31-36
[86]   ENDOTHELIUM-DERIVED RELAXING FACTOR FROM PULMONARY-ARTERY AND VEIN POSSESSES PHARMACOLOGICAL AND CHEMICAL-PROPERTIES IDENTICAL TO THOSE OF NITRIC-OXIDE RADICAL [J].
IGNARRO, LJ ;
BYRNS, RE ;
BUGA, GM ;
WOOD, KS .
CIRCULATION RESEARCH, 1987, 61 (06) :866-879
[87]   Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis [J].
Ihling, C ;
Szombathy, T ;
Bohrmann, B ;
Brockhaus, M ;
Schaefer, HE ;
Loeffler, BM .
CIRCULATION, 2001, 104 (08) :864-869
[88]   INHIBITION OF RESTENOSIS BY BERAPROST SODIUM (A PROSTAGLANDIN I-2 ANALOG) IN THE ATHEROSCLEROTIC RABBIT ARTERY AFTER ANGIOPLASTY [J].
ISOGAYA, M ;
YAMADA, N ;
KOIKE, H ;
UENO, Y ;
KUMAGAI, H ;
OCHI, Y ;
OKAZAKI, S ;
NISHIO, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (06) :947-952
[89]   Endothelin-1 signalling in vascular smooth muscle: Pathways controlling cellular functions associated with atherosclerosis [J].
Ivey, Melanie E. ;
Osman, Narin ;
Little, Peter J. .
ATHEROSCLEROSIS, 2008, 199 (02) :237-247
[90]   Arterial thrombosis-insidious, unpredictable and deadly [J].
Jackson, Shaun P. .
NATURE MEDICINE, 2011, 17 (11) :1423-1436